发明申请
- 专利标题: HEPATITIS C INHIBITORS AND USES THEREOF
- 专利标题(中): HEPATITIS C抑制剂及其用途
-
申请号: US15240753申请日: 2016-08-18
-
公开(公告)号: US20160355530A1公开(公告)日: 2016-12-08
- 发明人: Clarence J. Maring , John K. Pratt , William A. Carroll , Dachun Liu , David A. Betebenner , Douglas K. Hutchinson , Michael D. Tufano , Todd W. Rockway , Uwe Schoen , Axel Pahl , Andreas Witte
- 申请人: AbbVie Inc. , Abbott Products GmbH
- 主分类号: C07F7/18
- IPC分类号: C07F7/18 ; A61K31/4178 ; C07D417/14 ; A61K31/427 ; C07D413/14 ; A61K31/5377 ; C07D413/04 ; A61K31/5395 ; C07D471/04 ; A61K31/437 ; A61K31/506 ; A61K31/695 ; C07D405/04 ; A61K31/422
摘要:
This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
公开/授权文献
- US09567355B2 Hepatitis C inhibitors and uses thereof 公开/授权日:2017-02-14